Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1319-1326

  Huynh, K T ^a   Takei, Y ^a   Kuo, C ^a   Scolyer, R A ^b   Murali, R ^b   Chong, K ^a   Takeshima, L ^a   Sim, M S ^a   Morton, D L ^a   Turner, R R ^c   Thompson, J F ^b   Hoon, D S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CUTANEOUS MELANOMA; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; FEMALE; FOLLOW UP; GENE CONTROL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; SENTINEL LYMPH NODE METASTASIS; TUMOR GROWTH; ULCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FEMALE; GENES, NEOPLASM; HUMANS; INFANT; LYMPHATIC METASTASIS; MALE; MELANOMA; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84861613523     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10867.x     Document Type: Article

References (39)

1. Linabery AM, Ross JA,. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008; 112: 416-32.
2. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Available at: (last accessed 17 February 2012).
3. Pappo AS,. Melanoma in children and adolescents. Eur J Cancer 2003; 39: 2651-61.
4. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-11.
5. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-17.
6. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005; 115: 649-54.
7. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer 2007; 110: 614-24.
8. Howman-Giles R, Shaw HM, Scolyer RA, et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol 2010; 17: 138-43.
9. Sassen S, Shaw HM, Colman MH, et al. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center. Ann Surg Oncol 2008; 15: 630-7.
10. Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004; 11: 247-58.
11. Daniotti M, Ferrari A, Frigerio S, et al. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4a and gain of KIT. J Invest Dermatol 2009; 129: 1759-68.
12. Uribe P, Wistuba II, Solar A, et al. Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma. Am J Dermatopathol 2005; 27: 279-85.
13. Herman JG, Baylin SB,. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-54.
14. de Maat MF, Umetani N, Sunami E, et al. Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles. Mol Cancer Res 2007; 5: 461-71.
15. Hoon DS, Spugnardi M, Kuo C, et al. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 2004; 23: 4014-22.
16. Tanemura A, Terando AM, Sim MS, et al. CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 2009; 15: 1801-7.
17. Mori T, Martinez SR, O'Day SJ, et al. Estrogen receptor-α methylation predicts melanoma progression. Cancer Res 2006; 66: 6692-8.
18. Sunami E, Shinozaki M, Sim M-S, et al. Estrogen receptor and HER2/neu status affects epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Res 2008; 10: R46.
19. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-206.
20. Mills O, Messina JL,. Pediatric melanoma: a review. Cancer Control 2009; 16: 225-33.
21. de Maat M, Narita N, Bernard A, et al. Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma. Am J Pathol 2010; 177: 2347-56.
22. Sunami E, Shinozaki M, Higano CS, et al. Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem 2009; 55: 559-67.
23. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies. Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. J Clin Oncol 2005; 23: 9067-72.
24. Mori T, O'Day SJ, Umetani N, et al. Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol 2005; 23: 9351-8.
25. Marini A, Mirmohammadsadegh A, Nambiar S, et al. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma. J Invest Dermatol 2006; 126: 422-31.
26. Lin YC, You L, Xu Z, et al. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. Hum Gene Ther 2007; 18: 379-86.
27. Law MM, Wong JH,. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma. Am Surg 1994; 60: 362-6.
28. Lachiewicz AM, Berwick M, Wiggins CL, et al. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 2008; 144: 515-21.
29. Tcheung WJ, Marcello JE, Puja KP, et al. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma. J Am Acad Dermatol 2011; 65: e37-42.
30. Balch CM, Gershenwald JE, Soong SJ, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010; 28: 2452-9.
31. Haddad FF, Stall A, Messina J, et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999; 6: 144-9.
32. Shah NC, Gerstle JT, Stuart M, et al. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: The Hospital for Sick Children experience. J Pediatr Hematol Oncol 2006; 28: 496-500.
33. Toro J, Ranieri JM, Havlik RJ, et al. Sentinel lymph node biopsy in children and adolescents with malignant melanoma. J Pediatr Surg 2003; 38: 1063-5.
34. Nicholl MB, Elashoff D, Takeuchi H, et al. Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients. Ann Surg 2011; 253: 1-7.
35. Roaten JB, Partrick DA, Bensard D, et al. Survival in sentinel lymph node-positive pediatric melanoma. J Pediatr Surg 2005; 40: 988-92.
36. Conway WC, Faries MB, Nicholl MB, et al. Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol 2009; 16: 1548-52.
37. Gomez CR, Nomellini V, Faunce DE, et al. Innate immunity and aging. Exp Gerontol 2008; 43: 718-28.
38. Hegde UP, Chakraborty N, Kerr P, et al. Melanoma in the elderly patient: relevance of the aging immune system. Clin Dermatol 2009; 27: 537-44.
39. Moore-Olufemi S, Herzog C, Warneke C, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg 2011; 253: 1211-15.